Effect of Activated Vitamin D on Glucoparameters in HCV Seropositive and Seronegative Patients on Chronic Hemodialysis

REFERENCES

• Tangpricha V, Pearce EN, Chen TC, . Vitamin D insufficiency among free-living healthy young adults. Am J Med. 2002;112(8):659–662.
   PubMed Web of Science ®Google Scholar
• Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820.
   PubMed Web of Science ®Google Scholar
• Mertens PR, Muller R. Vitamin D and cardiovascular risk. Int Urol Nephrol. 2010;42(1):165–171.
   PubMed Web of Science ®Google Scholar
• Rammos G, Tseke P, Ziakka S, Vitamin D, The renin-angiotensin system, and insulin resistance. Int Urol Nephrol. 2008;40(2):419–426.
   PubMed Web of Science ®Google Scholar
• Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, . Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10:185–197.
   PubMed Web of Science ®Google Scholar
• Pittas AG, Lau J, Hu FB, Dawson-Hughes. B. The role of vitamin D and calcium in type 2 diabetes: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6): 2017–2029.
   PubMed Web of Science ®Google Scholar
• Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol. 1994;267(3):356–360.
   Google Scholar
• Bland R, Markovic D, Hills CE, . Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004;89–90:121–125.
   PubMed Web of Science ®Google Scholar
• Maestro B, Davila N, Carranza MC, Calle C. Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003;84(2–3):223–230.
   PubMed Web of Science ®Google Scholar
• Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem. 1985;260(15):8882–8891.
   PubMed Web of Science ®Google Scholar
• Maestro B, Molero S, Bajo S, Dávila N, Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3. Cell Biochem Funct. 2002;20(3):227–232.
   PubMed Web of Science ®Google Scholar
• Dunlop TW, Väisänen S, Frank C, . The human peroxisome proliferator-activated receptor δ gene is a primary target of 1alpha, 25‐dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol. 2005;349(2):248–260.
   PubMed Web of Science ®Google Scholar
• Maestro B, Campion J, Davila N, Calle. C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocrine J. 2000;47(4):383–391.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Alvestrand A, Smith D, . Insulin resistance in uremia. J Clin Invest. 1981;67:563–568.
   PubMed Web of Science ®Google Scholar
• Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30:980–986.
   PubMed Web of Science ®Google Scholar
• Mak RHK. Amelioration of hypertension and insulin resistance by 1,25-dihydroxycholecalciferol in hemodialysis patients. Pediatr Nephrol. 1992;6:345–348.
   PubMed Web of Science ®Google Scholar
• Mak RHK. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int. 1992;41:1049–1054.
   PubMed Web of Science ®Google Scholar
• Strózecki P, Kretowicz M, Odrow-Sypniewska G, Manitius J. The influence of intravenous 1, 25(OH)2D3 therapy on glucose metabolism in hemodialyzed patients with secondary hyperparathyroidism. Ren Fail. 2004;26:345–348.
   PubMed Web of Science ®Google Scholar
• Blair D, Byham-Gray L, Lewis E, McCaffrey S. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr. 2008;18:375–382.
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Pacini G, Barnas U, . Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int. 1995;47:200–206.
   Google Scholar
• Wolf M, Shah A, Gutierrez O, . Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72:1004–1013.
   PubMed Web of Science ®Google Scholar
• Bernsmeier C, Heim MH. Insulin resistance in chronic hepatitis C: Mechanisms and clinical relevance. Swiss Med Wkly. 2009;139:678–684.
   PubMed Web of Science ®Google Scholar
• Lonardo A, Adinolfi LE, Petta S, Craxì A, Loria P. Hepatitis C and diabetes: The inevitable coincidence? Expert Rev Anti Infect Ther. 2009;7:293–308.
   PubMed Web of Science ®Google Scholar
• Negro F, Alaei M. Hepatitis C virus and type 2 diabetes. World J Gastroenterol. 2009;15:1537–1547.
   PubMed Web of Science ®Google Scholar
• Konrad T, Zeuzem S, Vicini P, . Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-a. Eur J Clin Invest. 2000;30(2):111–121.
   PubMed Web of Science ®Google Scholar
• Petit JM, Bour JM, Galland-Jos C, . Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. Hepatology. 2001;35:279–283.
   Web of Science ®Google Scholar
• Chen LK, Hwang SJ, Tsai ST, . Glucose intolerance in Chinese patients with chronic hepatitis C. World J Gastroenterol. 2003;9:505–508.
   PubMed Web of Science ®Google Scholar
• Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes. Hepatology. 2003;38:1384–1392.
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Ide T, Taniguchi E, . Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol. 2007;102:570–576.
   PubMed Web of Science ®Google Scholar
• Douglas MW, George J. Molecular mechanisms of insulin resistance in chronic hepatitis C. World J Gastroenterol. 2009;15:4356–4364.
   PubMed Web of Science ®Google Scholar
• Strushkevich N, Usanov SA, Plotnikov AN, . Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol. 2008;380:95–106.
   PubMed Web of Science ®Google Scholar
• Chun RF, Adams JS, Hewison M. Back to the future: A new look at ‘old’ vitamin D. J Endocrinol. 2008;198:261–269.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, . Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
   PubMed Web of Science ®Google Scholar
• Von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient: A randomized, placebo-controlled trial. Br J Nutr. 2010;103(4):549–555.
   PubMed Web of Science ®Google Scholar
• Türk S, Yeksan M, Tamer N, Gürbilek M, . Effect of 1,25 (OH)2 D3 treatment on glucose intolerance in uremia. Nephrol Dial Transplant. 1992;7:1207–1212.
   PubMed Web of Science ®Google Scholar
• Naveh-Many T, Silver J. Vitamin D and the Parathyroid. 2nd ed. London: Elsevier; 2004.
   Google Scholar
• Christakos S, Gabrielides C, Rhoten WB. Vitamin D-dependent calcium binding proteins: Chemistry, distribution, functional considerations, and molecular biology. Endocr Rev. 1989;10:3–26.
   PubMed Web of Science ®Google Scholar
• Chiu KC, Chuang LM, Lee NP, . Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism. 2000;49:1501–1505.
   PubMed Web of Science ®Google Scholar
• Reis JP, von Muhlen D, Kritz-Silverstein D, . Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007;30:1549–1555.
   PubMed Web of Science ®Google Scholar
• Davidson HW, Rhodes CJ, Hutton JC. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature. 1988;333(6168):93–96.
   PubMed Web of Science ®Google Scholar
• Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S. The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol. 2007;103: 558–562.
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Mahon BD. D-hormone and the immune system. J Rheumatol Suppl. 2005;76:11–20.
   PubMedGoogle Scholar
• Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132:2169–2180.
   PubMed Web of Science ®Google Scholar
• Mlinar B, Marc J, Janez A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta. 2007;375:20–35.
   PubMed Web of Science ®Google Scholar
• Gunal AI, Celı’ker H, Celebı’ H, . Intravenous alfacalcidol improves insulin resistance in hemodialysis patients. Clin Nephrol. 1997;48:109–113.
   PubMed Web of Science ®Google Scholar
• Lin S, Lin Y, Lu K, . Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uremic patients with secondary hyperparathyroidism. Clin Sci. 1994;87:533–538.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Felsenfeld AJ, Williams C, . The effects of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol. 1991;2:1014–1020.
   PubMed Web of Science ®Google Scholar
• Quesada JM, Martin-Malo A, Santiago J, . Effect of calcitriol on insulin secretion in uremia. Nephrol Dial Transplant. 1990;5(12):1013–1017.
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Maggs DG, Spollett GR, . Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med. 1998;338(13):867–872.
   PubMed Web of Science ®Google Scholar
• Bonakdaran S, Ayatollahi H, Mojahedi MJ, . Impact of treatment with oral calcitriol on glucose intolerance and dyslipidemia(s) in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008;19(6):942–947.
   PubMedGoogle Scholar
• Roth J, Bonner weir S, Norman AW, . Immunohistochem-istry of vitamin D dependent calcium binding protein in chick pancreas exclusive localization in beta cells. Endocrinology. 1982;116:2216–2218.
   Google Scholar
• Christakos S, Norman AW. Studies on the mode of action of calciferol: Biochemical characterization of 1,25 dihydroxyvitamin D3 receptors in chick pancreas and kidney cytosol. Endocrinology. 1981;108:140–149.
   PubMed Web of Science ®Google Scholar
• Norman AW, Frankel BJ, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209:823–825.
   PubMed Web of Science ®Google Scholar
• Kadowski S, Norman AW. Demonstration that the vitamin D3 metabolite 1,25(OH)2 vitamin D3 and not 24R, 25(OH)2 vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes. 1985;34:315–321.
   PubMed Web of Science ®Google Scholar
• Luo C, Wong J, Brown M, Hooper M, Molyneaux L, Yue DK. Hypovitaminosis D in Chinese type 2 diabetes: Lack of impact on clinical metabolic status and biomarkers of cellular inflammation. Diab Vasc Dis Res. 2009;6(3):194–199.
   PubMed Web of Science ®Google Scholar